Prothena Plc Stock Market Value
| PRTA Stock | USD 8.85 0.08 0.90% |
| Symbol | Prothena |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. Anticipated expansion of Prothena directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Prothena Plc assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (5.14) | Revenue Per Share | Quarterly Revenue Growth 1.49 | Return On Assets | Return On Equity |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Prothena Plc's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Prothena Plc should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Prothena Plc's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Prothena Plc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Prothena Plc's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Prothena Plc.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Prothena Plc on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Prothena plc or generate 0.0% return on investment in Prothena Plc over 90 days. Prothena Plc is related to or competes with Kalvista Pharmaceuticals, Bicycle Therapeutics, 4D Molecular, Verastem, Olema Pharmaceuticals, Ventyx Biosciences, and Neumora Therapeutics. Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for lif... More
Prothena Plc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Prothena Plc's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Prothena plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 14.0 | |||
| Value At Risk | (4.47) | |||
| Potential Upside | 5.1 |
Prothena Plc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Prothena Plc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Prothena Plc's standard deviation. In reality, there are many statistical measures that can use Prothena Plc historical prices to predict the future Prothena Plc's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.14) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Prothena Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Prothena Plc February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 2.31 | |||
| Coefficient Of Variation | (1,363) | |||
| Standard Deviation | 3.03 | |||
| Variance | 9.18 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 14.0 | |||
| Value At Risk | (4.47) | |||
| Potential Upside | 5.1 | |||
| Skewness | 0.4651 | |||
| Kurtosis | 0.336 |
Prothena plc Backtested Returns
Prothena plc maintains Sharpe Ratio (i.e., Efficiency) of -0.0669, which implies the firm had a -0.0669 % return per unit of risk over the last 3 months. Prothena plc exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prothena Plc's Coefficient Of Variation of (1,363), risk adjusted performance of (0.05), and Variance of 9.18 to confirm the risk estimate we provide. The company holds a Beta of 1.67, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Prothena Plc will likely underperform. At this point, Prothena plc has a negative expected return of -0.2%. Please make sure to check Prothena Plc's skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Prothena plc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.44 |
Average predictability
Prothena plc has average predictability. Overlapping area represents the amount of predictability between Prothena Plc time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Prothena plc price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Prothena Plc price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 0.17 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:Check out Prothena Plc Correlation, Prothena Plc Volatility and Prothena Plc Performance module to complement your research on Prothena Plc. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Prothena Plc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.